AstraZeneca’s Covid-19 vaccine shows better-than-expected efficacy in U.S. trial

AstraZeneca said Monday that the Covid-19 vaccine it developed with the University of Oxford reduced both mild and serious forms of the disease, paving the way for a likely U.S. authorization of the vaccine.